ArticleOncotarget2015

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.

Niramol Savaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.